Last Updated： Aggregation Period:Dec 03, 2025～Dec 30, 2025
This ranking is based on the number of page views on our site.
Last Updated： Aggregation Period:Dec 03, 2025～Dec 30, 2025
This ranking is based on the number of page views on our site.
Last Updated： Aggregation Period:Dec 03, 2025～Dec 30, 2025
This ranking is based on the number of page views on our site.
856～858 item / All 858 items
![[Measurement Example] nAChR | Patchliner](https://image.mono.ipros.com/public/product/image/770/2001484501/IPROS18956288486656719670.jpeg?w=280&h=280)
We will introduce a case study of nAChR measurement using Patchliner.
Application Note: Nicotinic α3β4 receptors recorded on Nanion's Patchliner *For more details, please refer to the PDF document or feel free to contact us.
![[Measurement Example] NaV1.7 | Port-a-Patch](https://image.mono.ipros.com/public/product/image/020/2001485035/IPROS05500046213530348317.jpeg?w=280&h=280)
We will introduce a case study of NaV1.7 measurements using Port-a-Patch.
Application Note: Patch clamp recordings of hNaV1.7 on Nanion’s Port-a-Patch *For more details, please refer to the PDF document or feel free to contact us.
It has been announced that VX-150 and VX-548 target the Nav1.8 ion channel, showing potential for pain relief.
The paper using QPatch Compact focuses on the study of the inhibition of the Nav1.8 ion channel by two new analgesic compounds, VX-150 and VX-548. The Nav1.8 channel is a major target in sensory neurons that detect pain and is extremely important for pain-related therapies. This research, conducted by a professor's laboratory at Harvard Medical School, utilized the QPatch Compact semi-automated patch clamp system to perform voltage clamp recordings and analyze the effects of these compounds on Nav1.8 sodium currents. *For more details, you can view the related links. Please feel free to contact us for more information.*
